Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05138419 · ClinicalTrials.gov registry record · NA

A Pragmatic Approach to CKD Patient Education

A NA study, sponsored by University of Arkansas.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT05138419: Clinical Trial NA study, sponsored by University of Arkansas.

NCT05138419 is a NA study that was terminated before completion, run by University of Arkansas. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05138419, a NA study, was terminated before completion, sponsored by University of Arkansas.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

Over 350,000 adult Arkansans have chronic kidney disease (CKD) and 9 out of 10 (312,000) of these Arkansans are unaware of having it. A "Know Your Kidney Number" (eGFR) poster (KYKN) campaign is being launched statewide to increase CKD awareness and detection. As awareness increases, the demand for patient education will increase. Educating patients has proven to be effective in delaying CKD progression and establishing optimal renal replacement therapy (RRT) when needed. CKD patient education has historically been provided by nephrology clinicians. Yet most patients are not referred to nephrology until the patient is nearing the need for RRT. Novel pragmatic approaches to reaching and educating patients earlier in their disease state and partnering with a broader pool of clinicians that can provide the education is needed. Most problems related to CKD start when kidney function is \~45 %, earlier education can empower patients to make changes to protect their kidney function earlier and plan for RRT. University of Arkansas for Medical Sciences (UAMS) developed and copyrighted the "CKD: What You Need to Know" patient education system. Research showed almost 90% of the attendees could choose a modality after either tele-education (TE) or face to face (FTF) education. Home modality choices doubled. Patients were able to make informed choices regardless of the modality of education. Of those starting RRT 47% started on a home modality or received a transplant. This compares to 10% nationally. Both transplant and home dialysis have better outcomes and are less costly compared to in-center hemodialysis. Harp's Pharmacy has a successful medication therapy management (MTM) program where pharmacists are provided time for patient-centered activities for patients with diabetes (DM), hypertension (HTN), the 2 leading causes for CKD, and heart failure (HF), the leading cause of death in CKD. Thirty six percent of patients with DM will develop CKD and hypertension can be both

Primary Outcome

This primary study aim is to increase the subject's ability to select a dialysis modality. Descriptive statistics will be used to examine the trend in the subjects' ability to choose or not choose a dialysis modality. Descriptive statistics will be used to examine the trend of patients answers based on comparisons of responses on pre and post tests and evaluation form with the options of Incenter Hemodialysis (ICH), Home Hemodialysis (HH), Peritoneal Dialysis (PD), No Dialysis, don't have enough

Interventions

  • OTHER CKD "What You Need To Know" Workbook System
  • OTHER CKD Action Plan
  • OTHER CKD Web-based Resource List
  • OTHER Food Label reading exercise

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2023-02-13
Est. Completion 2024-10-23
Phase NA
University of Arkansas

318 total trials

Why NCT05138419 stopped before completion

NCT05138419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 4 interventions - of which CKD "What You Need To Know" Workbook System is the first listed.

NCT05138419 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05138419 about?

NCT05138419 is a clinical study titled "A Pragmatic Approach to CKD Patient Education". Over 350,000 adult Arkansans have chronic kidney disease (CKD) and 9 out of 10 (312,000) of these Arkansans are unaware of having it. A "Know Your Kidney Number" (eGFR) poster (KYKN) campaign is being launched statewide to increase CKD awareness and detection. As awareness increases, the demand for ...

What is the current status of trial NCT05138419?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2023-02-13. Estimated completion is 2024-10-23.

What interventions are being tested in trial NCT05138419?

The interventions under investigation include: CKD "What You Need To Know" Workbook System (OTHER), CKD Action Plan (OTHER), CKD Web-based Resource List (OTHER), Food Label reading exercise (OTHER).

Who is sponsoring clinical trial NCT05138419?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05138419's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05138419, the US trial registry maintained by the National Library of Medicine. NCT05138419 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.